The Brexit1 deadline has been extended once again – now to January
31, 2020 – and a withdrawal deal seems likely given the result of the December
12 general election. However, drug manufacturers and contract test laboratories
should be proactive in understanding the
potential regulatory considerations relating to commercial drug product release
testing and Brexit.
This article provides a brief overview of the EU-U.S. Mutual Recognition Agreement (MRA) and discusses considerations for implementing viable alternatives for testing to support EU, U.K. and U.S. drug product releases if and when Brexit moves ahead.
The last REACH deadline was in May 2018 and brought to a close the period of active information gathering on the safety of chemical products marketed in the EU/EEA. It has resulted in a massive database of safety information on a wide range of substances and heralds an exciting new phase of evolution in scientific and regulatory thinking. So, with the data in, the decision letters start to roll out.
What does career growth mean at Covance – and how can you
expect to navigate career moves within our global organization? Five
inspirational people recently shared their perspectives on what career growth
means to them at Covance and how they’re helping evolve the way we develop our people
and their careers.
Resource Groups at LabCorp and Covance are just one example of how we celebrate
diversity and develop an inclusive culture in the workplace. Our ASCEND young professional
resource group recently sponsored a Diwali celebration in partnership with the Covance
Princeton (NJ) Site Council.